UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −90,441−100.0% | Sold out | Holders |
| Q2 2025 | 90,441 | $847.0K | <0.1% | +31,003+52.2% | Added | Holders |
| Q1 2025 | 59,438 | $730.2K | <0.1% | −30,794−34.1% | Reduced | Holders |
| Q4 2024 | 90,232 | $1.19M | <0.1% | +751+0.8% | Added | Holders |
| Q3 2024 | 89,481 | $1.72M | <0.1% | −20,973−19.0% | Reduced | Holders |
| Q2 2024 | 110,454 | $2.27M | 0.1% | +2,023+1.9% | Added | Holders |
| Q1 2024 | 108,431 | $2.58M | 0.1% | +12,482+13.0% | Added | Holders |
| Q4 2023 | 95,949 | $2.07M | 0.1% | +95,949 | New | Holders |